Evidence map›Paper›PMID 39598364›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Novel Thiazole-Fused [4,5-

Nathan Broudic, Alexandra Pacheco-Benichou, Cécile Corbière, Blandine Baratte, Thomas Robert, Stéphane Bach, Hélène Solhi, Rémy Le Guével, Corinne Fruit, Thierry Besson

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nathan BroudicUniv Rouen Normandie, INSA Rouen Normandie, CNRS, COBRA UMR 6014, F-76000 Rouen, France.ORCID 0000-0002-9593-2817
Alexandra Pacheco-BenichouUniv Rouen Normandie, INSA Rouen Normandie, CNRS, COBRA UMR 6014, F-76000 Rouen, France.
Cécile CorbièreUniv Rouen Normandie, ABTE UR4651, F-76000 Rouen, France.ORCID 0000-0002-9802-3053
Blandine BaratteSorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, F-29680 Roscoff, France.ORCID 0000-0002-2064-9558
Thomas RobertSorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, F-29680 Roscoff, France.
Stéphane BachSorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, F-29680 Roscoff, France.ORCID 0000-0002-7186-7483
Hélène SolhiUniv Rennes, Plateform ImPACcell, BIOSIT, F-35000 Rennes, France.
Rémy Le GuévelUniv Rennes, Plateform ImPACcell, BIOSIT, F-35000 Rennes, France.
Corinne FruitUniv Rouen Normandie, INSA Rouen Normandie, CNRS, COBRA UMR 6014, F-76000 Rouen, France.ORCID 0000-0002-2878-4885
Thierry BessonUniv Rouen Normandie, INSA Rouen Normandie, CNRS, COBRA UMR 6014, F-76000 Rouen, France.ORCID 0000-0003-3025-6659

Funding

graduate school for research Xl-Chem ANR-18-EURE-0020 XL CHEMLabex SynOrg ANR-11-LABX-0029
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

4,5-dichloro-1,2,3-dithiazolium chloridecytotoxicityDYRK1A kinasekinase inhibitionmicrowave-assisted chemistrythiazoloquinazolinesthiazoloquinazolinones

Identifiers

PMID39598364
PMCPMC11597202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.